Honma, N., Inoue, T., Tsuchiya, N., Koizumi, A., Yamamoto, R., Nara, T., . . . Habuchi, T. (2020). Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib. Health Sci Rep.
Chicago-stil citatHonma, Naoko, et al. "Prognostic Value of Plasminogen Activator Inhibitor‐1 in Biomarker Exploration Using Multiplex Immunoassay in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib." Health Sci Rep 2020.
MLA-referensHonma, Naoko, et al. "Prognostic Value of Plasminogen Activator Inhibitor‐1 in Biomarker Exploration Using Multiplex Immunoassay in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib." Health Sci Rep 2020.